FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells

British Journal of Haematology

Volumn 106, Issue 1, 1999, Pages 40-46

  Davies, Faith E ^a   Rawstron, Andrew C ^a   Pratt, Guy ^a   O'Connor, Sheila ^a   Su'ut, Lela ^a   Blythe, David ^a   Fenton, James ^a   Claydon, David ^a   Child, J Anthony ^a   Jack, Andrew S ^a   Morgan, Gareth J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Aneuploidy; B lymphocytes; FICTION; Fluorescence in situ hybridization; Multiple myeloma

Indexed keywords

ARTICLE; B LYMPHOCYTE; CHROMOSOME 11; CHROMOSOME 3; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MYELOMA; PLASMA CELL; PRIORITY JOURNAL; STEM CELL;

ANEUPLOIDY; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MULTIPLE MYELOMA;

EID: 0032837847     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01506.x     Document Type: Article

References (17)

1. Bakkus, M.H.C., Heirman, C., Van Riet, I., Van Camp, B. & Thielemans, K. (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood, 80, 2326-2335.
2. Bakkus, M.H.C., Van Riet, I., Van Camp, B. & Thielemans, K. (1994) Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. British Journal of Haematology, 87, 68-74.
3. + peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain. Blood, 85, 436-447.
4. Billadeau, D., Ahmann, G., Greipp, P. & Van Ness, B. (1993) The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. Journal of Experimental Medicine, 178, 1023-1031.
5. Chen, B.J. & Epstein, J. (1996) Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood, 87, 1972-1976.
6. Drach, J., Schuster, J., Nowotny, H., Angerler, J., Rosenthal, F., Fiegl, M., Rothermundt, C., Gsur, A., Jager, U., Heinz, R., Lechner, K., Ludwig, H. & Huber, H. (1995) Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescent in-situ hybridisation. Cancer Research, 55, 3854-3859.
7. Flactif, M., Zandecki, M., Lai, J.L., Bernardi, F., Obein, V., Bauters, F. & Facon, T. (1995) Interphase fluorescent in-situ hybridisation (FISH) as a powerful tool in the detection of aneuploidy in multiple myeloma. Leukemia, 9, 2109-2114.
8. King, G., Payne, S., Walker, F. & Murray, G. (1997) A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. Journal of Pathology, 183, 237-241.
9. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, M. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridisation. Blood, 90, 526-534.
10. Perez-Simon, J.A., Garcia-Sanz, R., Tabernero, M.D., Almeida, J., Gonzalez, M., Fernandez-Calvo, J., Moro, M.J., Hernandez, J.M., San Miguel, J.F. & Orfao, A. (1998) Prognostic value of numerical chromosome aberrations in multiple myeloma: FISH analysis of 15 different chromosomes. Blood, 91, 3366-3371.
11. Rawstron, A.C., Davies, F.E., Owen, R.G., English, A., Pratt, G., Child, J.A., Jack., A.S. & Morgan, G.J. (1998) B lymphocyte suppression in multiple myeloma: a reversible phenomenon specifically affecting B progenitor cells and normal plasma cell precursors. British Journal of Haematology, 100, 176-183.
12. Rawstron, A.C., Owen, R.G., Davies, F.E., Johnson, R.J., Jones, R.A., Richards, S.J., Evans, P.A., Child, J.A., Smith, G.M., Jack, A.S. & Morgan, G.J. (1996) Circulating plasma cells in multiple myeloma: characterization and correlation with disease status. British Journal of Haematology, 97, 46-55.
13. Sahota, S.S., Leo, R., Hamblin, T.J. & Stevenson, F.K. (1996) Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood, 87, 746-755.
14. Smadja, N.V., Louvert, C., Isnard, F., Dutel, J.L., Grange, M.J., Varette, C. & Krulik, M. (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. British Journal of Haematology, 90, 619-624.
15. Tabernero, D., San Miguel, J.F., Garcia-Sanz, R., Najera, L., Garcia-Isidoro, M., Perez-Simon, J.A., Gonzalez, M., Wiegant, J., Raap, A.K. & Orlao, A. (1996) Incidence of chromosome numerical changes in multiple myeloma. American Journal of Pathology, 149, 153-161.
16. Zandecki, M., Bernardi, F., Genevieve, F., Lai, J.L., Preudhomme, C., Flactif, M., Cosson, A., Bauters, F. & Facon, T. (1997a) Involvement of peripheral blood cells in multiple myeloma: chromosomal changes are the rule within circulating plasma cells but not within B lymphocytes. Leukemia, 11, 1034-1039.
17. Zandecki, M., Lai, J.L., Genevieve, F., Bernardi, F., Volle-Remy, H., Blanchet, O., Francois, M., Cosson, A., Bauters, F. & Facon, T. (1997b) Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood, 90, 3682-3690.